You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

HIV and Substance Use: Addressing the Dual Epidemics

  • Authors: W. David Hardy, MD
  • CME / CE Released: 11/30/2016
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 11/30/2017, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This activity is intended for infectious disease/HIV specialists, primary care physicians, public health and preventive medicine specialists, nurses, and pharmacists.

The goal of this activity is to provide insight on the effect of substance use on HIV infection management.

Upon completion of this activity, participants will:

  1. Have increased knowledge regarding the challenges of caring for persons living with HIV infection and substance use


Disclosures

POLICY ON SPEAKER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins University School of Medicine (and the Institute for Johns Hopkins Nursing) that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the instructional materials.

FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:


Faculty

  • W. David Hardy, MD

    Adjunct Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; Senior Director of Evidence-Based Practices, Whitman-Walker Health, Washington, DC

    Disclosures

    Disclosure: W. David Hardy, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Calimmune, Inc.; Gilead Sciences, Inc.; Janssen Pharmaceuticals; ViiV Healthcare
    Received grants for clinical research from; Amgen Inc.; Bristol-Myers Squibb Company; Gilead Sciences, Inc.; Janssen Pharmaceuticals; Merck & Co., Inc.; ViiV Healthcare

    Dr Hardy does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Hardy does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Host

  • Taryn Brill

    Medical Journalist, New York, New York

    Disclosures

    Disclosure: Taryn Brill has disclosed no relevant financial relationships.

Editor

  • Julia Muino, MA

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Julia Muino has disclosed no relevant financial relationships.

  • Judith M. Orvos, ELS

    Script Writer, Washington, DC

    Disclosures

    Disclosure: Judith M. Orvos, ELS, has disclosed no relevant financial relationships.

CE Reviewer

  • Amy Bernard, MS, BSN, RN-BC

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.


Accreditation Statements


Medscape, LLC is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

    For Physicians

  • The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.

    The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

    Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; 0 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number 0461-0000-16-194-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

HIV and Substance Use: Addressing the Dual Epidemics

Authors: W. David Hardy, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / CE Released: 11/30/2016

Valid for credit through: 11/30/2017, 11:59 PM EST

processing....

  • Print